PTPN11 and hepatocellular carcinoma: Increased expression of SHP2 upregulates Wnt signals and facilitates EPCAM+ or CD133+ CSCs expansion by promoting the dedifferentiation of hepatoma cells and enhancing the self-renewal of liver CSCs [17].